Immunomodulation and RNA interference alter Hepatitis B Virus-specific CD8 T cell recognition of infected HepG2-NTCP.
Adrian KuiperyJuan Diego Sanchez VasquezAman MehrotraJordan J FeldHarry L A JanssenAdam J GehringPublished in: Hepatology (Baltimore, Md.) (2021)
Immunomodulation, and RNAi, but not nucleos(t)ide analogues, alter recognition of infected HepG2-NTCP by HBV-specific CD8 T cells. Understanding these changes will inform combination treatments for CHB.